CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Quidel's Leverage Ratio

QDEL's quarterly Leverage Ratio and Total Liabilities, Equity growth




QDEL Leverage Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Equity Change 146.15 % 138.06 % 58.99 % 19.95 % 31.37 %
Y / Y Total Liabilities Change 68.06 % 53.39 % 20.03 % 7.44 % -18.78 %
Leverage Ratio MRQ 0.41 0.4 0.47 0.59 0.6
Overall Ranking # # # # #
Seq. Equity Change 11.78 % 56.93 % 38.83 % 1.08 % 8.11 %
Seq. Total Liabilities Change 12.85 % 34.58 % 10.77 % -0.1 % 3 %



Leverage Ratio first quarter 2021 Comment
Due to net new borrowings of 12.85%, Leverage Ratio detoriated to 0.41, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the first quarter 2021, 127 other companies have achieved lower Leverage Ratio than Quidel. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are QDEL Customers?
Leverage Ratio first quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 128
Healthcare Sector # 419
Overall Market # 979


Leverage Ratio Statistics
High Average Low
2.34 0.64 0.15
(Dec 31 2017)   (Mar 31 2013)




Financial Statements
Quidel's Equity $ 1,490 Millions Visit QDEL's Balance sheet
Quidel's Total Liabilities $ 608 Millions Visit QDEL's Balance sheet
Source of QDEL's Sales Visit QDEL's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2021, within Biotechnology & Drugs Industry Leverage RatioMar 31 2021 MRQ Total LiabilitiesMar 31 2021 MRQ Equity
Royalty Pharma Plc  1.12 $ 11,031.873  Millions$ 9,837.033  Millions
Wave Life Sciences Ltd   1.08 $ 56.961  Millions$ 52.821  Millions
Establishment Labs Holdings Inc   1.08 $ 78.168  Millions$ 72.551  Millions
Adma Biologics Inc   1.03 $ 116.425  Millions$ 112.504  Millions
Infinity Pharmaceuticals Inc   1.00 $ 52.099  Millions$ 52.046  Millions
Cerecor Inc   0.91 $ 30.079  Millions$ 33.155  Millions
Emergent Biosolutions Inc   0.90 $ 1,377.300  Millions$ 1,522.800  Millions
Aytu Biopharma Inc  0.90 $ 128.407  Millions$ 143.150  Millions
Sangamo Therapeutics Inc   0.87 $ 406.740  Millions$ 469.417  Millions
Inhibrx Inc   0.86 $ 51.856  Millions$ 60.593  Millions
Unity Biotechnology Inc   0.85 $ 68.232  Millions$ 79.953  Millions
Soligenix Inc   0.82 $ 14.121  Millions$ 17.319  Millions
Gossamer Bio Inc   0.77 $ 210.385  Millions$ 272.084  Millions
Evelo Biosciences Inc   0.72 $ 63.461  Millions$ 87.839  Millions
Obalon Therapeutics Inc  0.72 $ 7.245  Millions$ 10.098  Millions
Allena Pharmaceuticals Inc   0.70 $ 16.359  Millions$ 23.503  Millions
Mitesco Inc   0.69 $ 1.625  Millions$ 2.349  Millions
Merus N v   0.68 $ 161.412  Millions$ 236.537  Millions
Cel sci Corporation  0.65 $ 19.033  Millions$ 29.332  Millions
Strongbridge Biopharma plc  0.64 $ 35.965  Millions$ 55.847  Millions
Beam Therapeutics Inc   0.64 $ 270.812  Millions$ 422.429  Millions
Vir Biotechnology Inc   0.64 $ 414.765  Millions$ 650.951  Millions
Cyanotech Corp  0.63 $ 10.663  Millions$ 17.041  Millions
Nexien Biopharma Inc   0.61 $ 0.013  Millions$ 0.021  Millions
Regenxbio Inc   0.59 $ 324.938  Millions$ 554.504  Millions
Champions Oncology Inc   0.58 $ 4.306  Millions$ 7.428  Millions
Chromadex Corporation  0.57 $ 25.161  Millions$ 43.832  Millions
Curis Inc   0.56 $ 68.069  Millions$ 121.915  Millions
Armata Pharmaceuticals Inc   0.55 $ 18.833  Millions$ 34.012  Millions
Axcella Health Inc   0.53 $ 32.822  Millions$ 61.658  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JNJ's Profile

Stock Price

JNJ's Financials

Business Description

Fundamentals

Charts & Quotes

JNJ's News

Suppliers

JNJ's Competitors

Customers & Markets

Economic Indicators

JNJ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071